Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dacarbazine × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 73 Lymphoid 53 Sarcoma 18 CNS 3 Thoracic 2 Head & Neck 2 Endocrine 2 Other solid neoplasm 1 NET 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Interventions

Cisplatin 136 Carboplatin 115 pembrolizumab 113 Paclitaxel 94 Injections 90 Pemetrexed 88 Gemcitabine 80 Irinotecan 70 Cyclophosphamide 66 Docetaxel 61 Nivolumab 60 Bevacizumab 57 Fluorouracil 47 Oxaliplatin 45 Capecitabine 43 atezolizumab 41 Leucovorin 40 tislelizumab 37 Etoposide 36 toripalimab 30 fludarabine 28 Ipilimumab 28 Topotecan 26 Drug Therapy 26 Radiotherapy 25 durvalumab 24 Early Intervention, Educational 24 Vincristine 23 Doxorubicin 23 Specimen Handling 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05898451 2023-06-12

R-2

Refnot-Pharm Ltd

Phase 2 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡